Immunotoxins.
Immunotoxins (ITs) are chimeric molecules constructed by covalently conjugating monoclonal antibodies (MoAbs) to plant or bacterial toxins (e.g. ricin or pseudomonas exotoxin). The antibody moiety allows specific targeting of ITs to tumor-associated antigens, while the toxin moiety is responsible for cell killing by irreversible inactivation of protein synthesis. Since ITs must reach the cytosol to kill cells, the rates of endocytosis, the pathways of intracellular routing, and the rates of translocation to the cytoplasm are important determinants of the efficacy of an IT. Promising in vitro and in vivo IT results have been reported by many groups, and phase I clinical trials in cancer patients are currently underway.
Press
O W
OW
Department of Medicine, University of Washington, Seattle.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D001427:Bacterial Toxins / Q000008:administration & dosage* / Q000627:therapeutic use; D004705:Endocytosis; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D000922:Immunotoxins / Q000008:administration & dosage* / Q000627:therapeutic use; D010940:Plant Proteins / Q000008:administration & dosage* / Q000627:therapeutic use; D012276:Ricin / Q000008:administration & dosage / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D001427:Bacterial Toxins; D000922:Immunotoxins; D010940:Plant Proteins; D012276:Ricin